Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 Expression.

Minehiko Inomata,Naoki Takata,Isami Mizushima,Kenji Azechi,Kana Hayashi,Kotaro Tokui,Chihiro Taka,Seisuke Okazawa,Kenta Kambara,Shingo Imanishi,Toshiro Miwa,Ryuji Hayashi,Shoko Matsui,Kazuyuki Tobe

Cancer diagnosis & prognosis（2021）

引用 2|浏览2

暂无评分

摘要

Our findings suggest that a subset of patients with non-squamous cell non-small cell lung cancer who show negative or low tumor PD-L1 expression could benefit from ICI monotherapy.

查看译文

关键词

Immune checkpoint inhibitor,PD-L1,lung cancer,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要